-
Something wrong with this record ?
2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists
T. Smutny, A. Nova, M. Drechslerová, A. Carazo, L. Hyrsova, ZR. Hrušková, J. Kuneš, M. Pour, M. Špulák, P. Pavek,
Language English Country United States
Document type Journal Article
- MeSH
- Hep G2 Cells MeSH
- Quinazolines chemical synthesis chemistry pharmacology MeSH
- Hepatocytes drug effects metabolism MeSH
- Enzyme Inhibitors chemical synthesis chemistry pharmacology MeSH
- Humans MeSH
- Models, Molecular MeSH
- Molecular Structure MeSH
- Receptors, Cytoplasmic and Nuclear agonists MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Constitutive androstane receptor (CAR) is a key regulator of xenobiotic and endobiotic metabolism. Together with pregnane X (PXR) and aryl hydrocarbon (AHR) receptors, it is referred to as "xenobiotic receptor". The unique properties of human CAR, such as its high constitutive activity, both direct (ligand-binding domain-dependent) and indirect activation have hindered the discovery of direct selective human CAR ligands. Herein, we report a novel class of direct human CAR agonists in a group of 2-(3-methoxyphenyl)quinazoline derivatives. The compounds are even more potent activators of human CAR than is prototype 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime (CITCO). The three most potent ligands are at the same time extremely potent activators of the other xenobiotic or hormonal receptors, namely PXR, AHR, and vitamin D receptor, which regulate major xenobiotic-metabolizing enzymes and efflux transporters. Thus, the novel CAR ligands can be also considered as constituting the first class of potent pan-xenobiotic receptor ligands that can serve as potential antidotes boosting overall metabolic elimination of xenobiotic or toxic compounds.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024016
- 003
- CZ-PrNML
- 005
- 20170720122409.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.5b01891 $2 doi
- 035 __
- $a (PubMed)27145071
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Smutny, Tomas
- 245 10
- $a 2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists / $c T. Smutny, A. Nova, M. Drechslerová, A. Carazo, L. Hyrsova, ZR. Hrušková, J. Kuneš, M. Pour, M. Špulák, P. Pavek,
- 520 9_
- $a Constitutive androstane receptor (CAR) is a key regulator of xenobiotic and endobiotic metabolism. Together with pregnane X (PXR) and aryl hydrocarbon (AHR) receptors, it is referred to as "xenobiotic receptor". The unique properties of human CAR, such as its high constitutive activity, both direct (ligand-binding domain-dependent) and indirect activation have hindered the discovery of direct selective human CAR ligands. Herein, we report a novel class of direct human CAR agonists in a group of 2-(3-methoxyphenyl)quinazoline derivatives. The compounds are even more potent activators of human CAR than is prototype 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime (CITCO). The three most potent ligands are at the same time extremely potent activators of the other xenobiotic or hormonal receptors, namely PXR, AHR, and vitamin D receptor, which regulate major xenobiotic-metabolizing enzymes and efflux transporters. Thus, the novel CAR ligands can be also considered as constituting the first class of potent pan-xenobiotic receptor ligands that can serve as potential antidotes boosting overall metabolic elimination of xenobiotic or toxic compounds.
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a inhibitory enzymů $x chemická syntéza $x chemie $x farmakologie $7 D004791
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a hepatocyty $x účinky léků $x metabolismus $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a chinazoliny $x chemická syntéza $x chemie $x farmakologie $7 D011799
- 650 _2
- $a receptory cytoplazmatické a nukleární $x agonisté $7 D018160
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nova, Alice $u Institute of Molecular and Translation Medicine, Faculty of Medicine, Palacky University in Olomouc , Hnevotinska 5, CZ-779 00 Olomouc, Czech Republic.
- 700 1_
- $a Drechslerová, Marcela
- 700 1_
- $a Carazo, Alejandro
- 700 1_
- $a Hyrsova, Lucie
- 700 1_
- $a Hrušková, Zuzana Rania
- 700 1_
- $a Kuneš, Jiří
- 700 1_
- $a Pour, Milan
- 700 1_
- $a Špulák, Marcel
- 700 1_
- $a Pavek, Petr
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 59, č. 10 (2016), s. 4601-10
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27145071 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720122902 $b ABA008
- 999 __
- $a ok $b bmc $g 1239697 $s 984929
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 59 $c 10 $d 4601-10 $e 20160512 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20170720